Literature DB >> 1490340

Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae.

M K Johnson1, J A Hobden, R J O'Callaghan, J M Hill.   

Abstract

In earlier experiments on the role of the cytolytic toxin pneumolysin in ocular infections with pneumococcus, we found that a strain carrying a deletion in the gene encoding pneumolysin was considerably less virulent than wild type when tested in an intracorneal model of keratitis in the rabbit. To confirm this result, we have constructed a strain in which pneumolysin activity was restored by transformation of the deleted strain with a plasmid bearing the complete pneumolysin gene. Hemolytic titers of pneumolysin indicated that only one copy of the plasmid per bacterium expresses the pneumolysin gene in this strain. The virulence of this strain was compared with that of wild type and deleted strains transformed with the vector lacking the pneumolysin gene. Slit lamp examination (SLE) scores for eyes infected with the restored strain were similar to those for eyes infected with wild type and significantly greater than those for the pneumolysin-deleted strain. Molecular analysis of bacteria recovered from infected corneas showed that the vector plasmid was retained; however, in most isolates of the restored strain, the plasmid underwent an excision and lost the pneumolysin gene. The cloned gene apparently persisted long enough to induce the pathologic changes, and the results confirm the importance of pneumolysin as a virulence factor in ocular infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490340     DOI: 10.3109/02713689208999547

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  11 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Sidney D Taylor; Nathan A Tullos; Rhonda R Caston; Sherrina N Dixon; Moon H Nahm; Robert L Burton; Hilary Thompson; Larry S McDaniel; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

3.  Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.

Authors:  R B Alcantara; L C Preheim; M J Gentry
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Mary E Marquart
Journal:  J Bacteriol Parasitol       Date:  2011

5.  Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.

Authors:  Erin W Norcross; Nathan A Tullos; Sidney D Taylor; Melissa E Sanders; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

6.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 7.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

8.  Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Authors:  Mary E Marquart; Kathryn S Monds; Clare C McCormick; Sherrina N Dixon; Melissa E Sanders; Julian M Reed; Larry S McDaniel; Armando R Caballero; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

9.  Host response and bacterial virulence factor expression in Pseudomonas aeruginosa and Streptococcus pneumoniae corneal ulcers.

Authors:  Rajapandian SivaGanesa Karthikeyan; Jeganathan Lakshmi Priya; Sixto M Leal; Jonida Toska; Arne Rietsch; Venkatesh Prajna; Eric Pearlman; Prajna Lalitha
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

10.  Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.

Authors:  Katie L Propst-Graham; Laurel C Preheim; Elizabeth A Vander Top; Mary U Snitily; Martha J Gentry-Nielsen
Journal:  BMC Microbiol       Date:  2007-10-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.